Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.

MLA

Pabel, Steffen, et al. “Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.” Frontiers in Physiology, vol. 12, Nov. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fphys.2021.752370.

APA

Pabel, S., Hamdani, N., Singh, J., & Sossalla, S. (2021). Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. Frontiers in Physiology, 12, 1–11. https://doi.org/10.3389/fphys.2021.752370

Chicago

Pabel, Steffen, Nazha Hamdani, Jagdeep Singh, and Samuel Sossalla. 2021. “Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.” Frontiers in Physiology 12 (November): 1–11. doi:10.3389/fphys.2021.752370.